文献速递疼痛医学

潜在慢性疼痛疾病中止痛药处方的发病率和患病率

Incidence and Prevalence of Pain Medication Prescriptions in Pathologies with a Potential for Chronic Pain.
PubMed 文献 · Anesthesiology · 2024-01-01

该回顾性队列研究利用TriNetX电子健康记录,分析了10个潜在慢性疼痛队列(总n=9,357,584)在2012至2022年间五类止痛药处方的年度发病率和患病率。结果显示NSAIDs、阿片类、神经病理性药物和肌肉松弛剂的处方发病率总体增加,仅苯二氮䓬类在特定队列中显著下降,PSPS 2型和复杂区域疼痛综合征患者使用药物种类广泛。

要点

  • 2012至2022年,多数队列NSAIDs处方显著增加,但纤维肌痛和PSPS 2型除外。
  • 阿片类药物处方在CRPS、子宫内膜异位症、骨关节炎和PSPS 2型患者中增加。
  • 仅苯二氮䓬类在CRPS 1型、纤维肌痛和PSPS 2型患者中呈显著下降趋势。

核心结论

  • 过去11年,NSAIDs和对乙酰氨基酚、阿片类、神经病理性药物及肌肉松弛剂的处方发病率增加,仅苯二氮䓬类在特定队列中显著下降。
  • PSPS 2型和复杂区域疼痛综合征(两型)患者使用多种止痛药物类别。

研究设计与样本

  • 回顾性队列研究,使用TriNetX全球协作网络电子健康记录。
  • 纳入10个 distinct 队列,总样本量9,357,584名患者。
  • 提取五类止痛药处方:NSAIDs和对乙酰氨基酚、阿片类、加巴喷丁类、神经病理性情绪药物、肌肉松弛剂。
  • 评估2012至2022年共11年的年度发病率和患病率。

主要发现

  • 2012至2022年,除纤维肌痛和PSPS 2型患者外,NSAIDs处方显著增加。
  • CRPS、子宫内膜异位症、骨关节炎和PSPS 2型患者的阿片类药物处方随时间增加。
  • 除纤维肌痛外,所有队列的肌肉松弛剂处方均增加。
  • CRPS(两型)和PSPS 2型患者的神经病理性情绪药物处方发病率高。
  • 仅苯二氮䓬类处方呈下降趋势,在CRPS 1型、纤维肌痛和PSPS 2型患者中时间趋势显著下降。

临床怎么用

  • 临床医生应为潜在慢性疼痛患者定期评估止痛药处方模式,关注阿片类和神经病理性药物的增加趋势。
  • 对PSPS 2型和CRPS患者,需注意其可能使用多种止痛药物,应加强药物整合与监测。
  • 苯二氮䓬类处方在特定队列中下降,可继续关注其合理使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heightened risks of dependence, addiction, anxiolytic effects, or prescription overdose death due to long-term use of pain medication have increased awareness about extended pain medication use in chronic pain populations. The goal of this study was to evaluate the incidence and prevalence of pain medication prescriptions from 2012 to 2022 in common pathologies with a potential for chronic pain. METHODS: A retrospective cohort study was conducted using electronic health records from TriNetX (Cambridge, Massachusetts) Global Collaborative Network. For 10 distinct cohorts (total n = 9,357,584 patients), pain medication prescriptions were extracted for five classes, namely nonsteroidal anti-inflammatory drug (NSAIDs) and acetaminophen, opioids, gabapentinoids, neuropathic mood agents, and muscle relaxants. Annual incidence and prevalence of each class of medication were evaluated for the past 11 yr. RESULTS: From 2012 to 2022, there was a significant increase in prescriptions of NSAIDs, except for patients with fibromyalgia, and persistent spinal pain syndrome (PSPS) type 2. Interestingly, over time, prescriptions of opioids in patients with complex regional pain syndrome, endometriosis, osteoarthritis, and PSPS type 2 increased, as did prescriptions of muscle relaxants for all cohorts except those with fibromyalgia. Incidence of prescriptions of neuropathic mood agents is high for patients with complex regional pain syndrome (both types) and PSPS type 2. Only for benzodiazepines did there seem to be a decline over the years, with a significantly decreased time trend in patients with complex regional pain syndrome type 1, fibromyalgia, and PSPS type 2. CONCLUSIONS: During the last 11 yr, an increase in incidence of NSAIDs and acetaminophen, opioids, neuropathic agents, and muscle relaxants was observed. Only prescriptions of benzodiazepines significantly decreased over time in specific cohorts. Overall, patients with PSPS type 2 and complex regional pain syndrome (both types) consume a broad variety of pain medication classes.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Goudman L, Moens M, Pilitsis JG, et al. Incidence and Prevalence of Pain Medication Prescriptions in Pathologies with a Potential for Chronic Pain. Anesthesiology. 2024. PMID: 38081041. doi:10.1097/ALN.0000000000004863

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。